×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVBP – arrivent biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVBP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/26
06:43 am
avbp
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at Truist Financial Corporation to a "strong-buy" rating.
11/25
08:44 am
avbp
ArriVent BioPharma (NASDAQ:AVBP) was given a new $43.00 price target on by analysts at Truist Financial Corporation.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) was given a new $43.00 price target on by analysts at Truist Financial Corporation.
11/11
03:35 pm
avbp
ArriVent BioPharma (NASDAQ:AVBP) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $31.00. They now have a "buy" rating on the stock.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) had its price target lowered by analysts at Citigroup Inc. from $33.00 to $31.00. They now have a "buy" rating on the stock.
11/10
08:18 am
avbp
ArriVent BioPharma Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Low
Report
ArriVent BioPharma Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/10
08:00 am
avbp
ArriVent BioPharma Reports Third Quarter 2025 Financial Results
Low
Report
ArriVent BioPharma Reports Third Quarter 2025 Financial Results
10/3
03:30 pm
avbp
ArriVent BioPharma (NASDAQ:AVBP) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
9/22
04:05 pm
avbp
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
Low
Report
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
9/9
08:28 am
avbp
Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer [Yahoo! Finance]
Low
Report
Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:53 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
11/10
08:02 am
avbp
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
Low
Report
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
11/10
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
11/5
11:27 am
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
10/30
02:04 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
10/17
06:06 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
10/15
04:07 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Medium
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
9/9
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Sep 09
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Sep 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: